Ferrara G, Mastrangelo G, Barone P, La Torre F, Martino S, Pappagallo G
Pediatr Rheumatol Online J. 2018; 16(1):46.
PMID: 29996864
PMC: 6042421.
DOI: 10.1186/s12969-018-0255-8.
Okihiro A, Hasija R, Fung L, Cameron B, Feldman B, Laxer R
Pediatr Rheumatol Online J. 2018; 16(1):17.
PMID: 29540190
PMC: 5853069.
DOI: 10.1186/s12969-018-0233-1.
Deng D, Yee K, Burkhalter W, Okimoto K, Kon K, Kurahara D
Pediatr Rheumatol Online J. 2014; 12:14.
PMID: 24808798
PMC: 4012245.
DOI: 10.1186/1546-0096-12-14.
Smith E, Foster H, Beresford M
Br J Clin Pharmacol. 2014; 79(3):379-94.
PMID: 24750505
PMC: 4345949.
DOI: 10.1111/bcp.12406.
Castillo R, De La Pena W, Marzan K
Curr Rheumatol Rep. 2013; 15(4):322.
PMID: 23443616
DOI: 10.1007/s11926-013-0322-6.
Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis.
Kemper A, Van Mater H, Coeytaux R, Williams Jr J, Sanders G
BMC Pediatr. 2012; 12:29.
PMID: 22420649
PMC: 3340294.
DOI: 10.1186/1471-2431-12-29.
Rates of malignancy associated with juvenile idiopathic arthritis and its treatment.
Beukelman T, Haynes K, Curtis J, Xie F, Chen L, Bemrich-Stolz C
Arthritis Rheum. 2012; 64(4):1263-71.
PMID: 22328538
PMC: 3315602.
DOI: 10.1002/art.34348.
Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?.
Cron R, Beukelman T
Pediatr Rheumatol Online J. 2010; 8:23.
PMID: 20712883
PMC: 2931479.
DOI: 10.1186/1546-0096-8-23.
[Methotrexate in the therapy of juvenile idiopathic arthritis].
Holzinger D, Frosch M, Foll D
Z Rheumatol. 2010; 69(6):496-504.
PMID: 20632181
DOI: 10.1007/s00393-010-0633-1.
Recommendations for the use of methotrexate in juvenile idiopathic arthritis.
Niehues T, Lankisch P
Paediatr Drugs. 2006; 8(6):347-56.
PMID: 17154642
DOI: 10.2165/00148581-200608060-00003.
Juvenile idiopathic arthritis: the paediatric perspective.
Jordan A, McDonagh J
Pediatr Radiol. 2006; 36(8):734-42.
PMID: 16688446
DOI: 10.1007/s00247-006-0165-7.
Evidence-based use of methotrexate in children with rheumatic diseases: a consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria.
Niehues T, Horneff G, Michels H, Hock M, Schuchmann L
Rheumatol Int. 2005; 25(3):169-78.
PMID: 15688190
DOI: 10.1007/s00296-004-0537-y.
Use of methotrexate in juvenile idiopathic arthritis.
Ramanan A, Whitworth P, Baildam E
Arch Dis Child. 2003; 88(3):197-200.
PMID: 12598376
PMC: 1719480.
DOI: 10.1136/adc.88.3.197.
